We are very honoured to count as BioFIT 2016 Sponsors: GSK, Boehringer Ingelheim, Roche, Novo Nordisk, LFB, De Gaulle Fleurance & Associés, Cabinet Beau de Loménie, INPI, SATT Network, Biobanques, Pharma Logistics Club… 

Like them, join the BioFIT 2016 Sponsors and get the opportunity to:

• Associate your image to the main tech transfer & partnering event of the sector
• Bring out your ideas and technologies to the key players of innovation in Life Sciences
•  Enhance your visibility at an international scale and
• Show your expertise thanks to specific communication tools

Discover all the Sponsorship opportunities

Contact us to receive a personalised offer that will suit your needs!

The BioFIT 2016 Agenda is now available online, don’t wait to discover this 5th edition preliminary programme:

• BioFIT 2016 Steering Committee members
• Partnering on BioFIT
• Some more details about the Conferences Programme and its three tracks
• The detailed agenda of BioFIT and its hosted events – so you can start planning your visit
• The hosted events
• Your visibility opportunities

Discover BioFIT 2016 Agenda

Dear BioFITers,

This week, we have the pleasure to welcome Roberto Gradnik, President of the European Biopharmaceutical Enterprise Network, Former CEO of Stallergenes and VP of Merck Serono, in BioFIT 2016 conference programme.

Now CEO of Ixaltis, which freshly raised €8M in Series A last May, Mr. Gradnik will share his opinion alongside Thierry Laugel, Managing Partner of Kurma Partners, and Philippe Monteyne, VC Partner at Fund +, in a session entitled “How to spark the interest of VCs for Series A financing”?

Mr. Gradnik will share his experience and tell the BioFITers all about Series A, we can’t wait to see that !

You want to be a speaker at BioFIT 2016 ? Check out the programme and contact us!

Dear BioFITers,

 You certainly know that an event exists thank to the support of its trusty Steering Committee. At BioFIT, we have the pleasure to benefit from the expertise of a committee as diverse in backgrounds as in personalities, we are very proud to count them by our side and we ‘d like to share this with you.

Meet the driven 27:

Pharma, Biotech:

On one hand, we have 11 experts from pharma and biotech, currently based in 6 different countries and having global experience of collaborations in Life Sciences.

• Zeina ANTOUN, Clinical Research Director, GSK – GlaxoSmithKline (FR)
• Maria BOBADILLA, Senior Director, Extending Innovation Network, Roche (CH)
• Adrian CARTER, Corporate Vice President and Global Head of Discovery Research Coordination, Boehringer Ingelheim (DE)
• Sami CHTOUROU, Director of technology platforms and innovation, LFB (FR)
• Florence DAL DEGAN, R&D Innovation Sourcing Director, Novo Nordisk (DK)
• Isabelle DIEUZY-LABAYE, Former Director, Strategic Alliances, Zoetis (FR)
• Guy HELIN, CEO, Syngulon (BE)
• Sarah HOLLAND, Head of Europe, External Science & Partnering, Sanofi (FR)
• Stephan LENSKY, Chief Operating and Chief Business Officer, EpimAb Biotherapeutics (CN)
• Sabrina LESAGE, Strategic Alliances Manager, Pfizer (FR)
• Frédéric SCAEROU, Director, Scientific Affairs Oncology, Ipsen Innovation (FR)

 

Academia, TTOs:

On the other hand, 6 top-notch profiles to represent academia and Tech Transfer Offices from Europe and overseas, ready to share their wisdom and make BioFIT an indispensable tool.

• Hervé ANSANAY, Operations Director, SATT AxLR (FR)
• Ivan BAINES, Chief Operating Officer, Max Planck Institute of Molecular Cell Biology and Genetics (DE)
• Garold BREIT, Director, City of Charleston, Technology Business Development Initiative (USA)
• Nicolas CARBONI, President, SATT Conectus Alsace (FR)
• Jean-Luc CHAGNAUD, Healthcare Business Development Manager & Intellectual Property Manager, Aquitaine Science Transfert (FR)
• Matthieu FISICHELLA, Life Science Expert, SATT Nord (FR)
• Esther LANGE, Industry Liaison Manager, Ascenion (DE)

 

Associations, Clusters, Investors & Law firms:

To complete this impressive group, 9 experienced professionals from associations, venture capital firms, law firms and clusters, ready to help you promote and protect your assets.

 

• Claude-Alain CUDENNEC, General Director, AFSSI – Association Française des Sociétés de Services et d’Innovation (FR)
• Marco FIORINI, General Secretary, Aviesan – French National Alliance for Life Sciences and Health (FR)
• Barbara FREISCHEM, Managing Director, EBE – European Biopharmaceutical Enterprises (BE)
• Didier FROMMWEILER, General Manager, Alsace BioValley (FR)
• Sara NUNEZ-GARCIA, Senior Associate, Sofinnova Partners (FR)
• Christian POLICARD, Administrator and President of the Business Development Committee, France Biotech (FR)
• Emilie ROYERE, Director, Eurobiomed (FR)
• Cécile THEARD-JALLU, Partner Attorney, De Gaulle Fleurance & Associés (FR)
• Etienne VERVAECKE, General Manager, Eurasante & NHL cluster (FR)

 

Recommending speakers, designing the conference programme in a constant will to improve BioFIT, the Steering Committee member’s role is a corner stone to the event’s organization.

It is our greatest pleasure to welcome two brand new speakers this week, to complete the already impressive list of experts that have been willing to come and share their opinion in BioFIT 2016.

Two good news to share with the BioFITers :

Opened by a special 30-minute keynote session of Peter Gruss, former president of the Max Planck Society, the plenary session held right after will be moderated by no one else than John Carroll, former editor-in-chief of Fierce Biotech, who launched this summer the very addictive Life Sciences newsfeed Endpoints.

Second of all, joining Michèle Ollier, founder of Medicxi Venture, and Sam Fazeli, Analyst at Bloomberg Intelligence, we are welcoming Soren Moller, Managing Partner at Novo Seeds to talk on the very exciting session “How to create a European seed capital market?” planned to be held on November 30^th at 2.30 pm.

Do you want to speak at BioFIT 2016 ? Check out the conference programme and contact us!

Dear BioFITers,

This is our great pleasure to announce that the session “How can industry and investor incubator models accelerate research translation?” welcomes two heavy-league speakers within its panel.

First, Sabine Louet, Editor at Euroscientist in Dublin, and founder of SciencePOD , will moderate the panel, that Christophe Guichard, Director of Fondation Eclosion freshly joinded.

Completed by Magnus Bjorsne, Director of AstraZeneca BioVenture Hub and by Einat Zisman, Head of FuturX, the panel ought to be completed with a biotech that benefit from an incubator support, and that is now willing to testify on that past experience.

Do you want to join that panel, or BioFIT 2016 conference programme ? Contact us!

We are very pleased to count, this year again, Boehringer Ingelheim among our Sponsors, as a Bronze Sponsor.

As this organisation, join the BioFIT 2016 Sponsors and get the opportunity to:

• Associate your image to the main tech transfer & partnering event of the sector
• Bring out your ideas and technologies to the key players of innovation in Life Sciences
• Enhance your visibility at an international scale
• Show your expertise thanks to specific communication tools

Discover all the Sponsorship opportunities.

Contact us to receive a personalised offer that will suit your needs.

Dear BioFITers,

We hope that you are spending a lovely summer whether you are working, travelling or relaxing. BioFIT great news has no holidays, and we are very happy to reveal BioFIT 2016 keynote speaker:

We are very honoured to announce that Peter Gruss, former president of the Max Planck Society will open BioFIT 2016 plenary session with a 30-minute keynote presentation on  new models required for Academic-/biotech-/pharma-cooperations 

Professor Gruss keynote opening will then be followed by an-hour debate on “Is Europe competitive enough for innovation in Life Sciences?” discussed by a panel of experts, among who Piyush Unalkat, Principal of Equity Investments and Head of Technology Transfer & IP Investments at the Euroean Investment Fund, and Ron Newbold, VP External R&D Innovation, Pfizer Worldwide Research and Development for Pfizer USA

Don’t miss the session, be sure to be in Lille 30^th November 2016 from 11.30 am to 1.00pm

As you know, the heart of the BioFIT 2016 event is the partnering activity: the one-to-one meetings. Thanks to the efficient partneringONE platform from EBD Group, you can pre-scheduled those meetings one month before the event and get the opportunity to meet potential partners and investors.

On the platform:

• Create your profile
• Maximize your time by selecting who you want to meet
• Send requests
• Meet your future partners (up to 30 meetings in 2 days)

Don’t miss this opportunity and register now for BioFIT 2016!